References
- Busse WW, Melén E, Menzies-Gow AN. Holy Grail: the journey towards
disease modification in asthma. Eur Respir Rev. 2022 Feb
22;31(163):210183. Doi: 10.1183/16000617.0183-2021. PMID: 35197266;
PMCID: PMC9488532
- Turner D, Ricciuto A, Lewis A, D’Amico F, Dhaliwal J, Griffiths AM,
Bettenworth D, Sandborn WJ, Sands BE, Reinisch W, Schölmerich J,
Bemelman W, Danese S, Mary JY, Rubin D, Colombel JF, Peyrin-Biroulet
L, Dotan I, Abreu MT, Dignass A; International Organization for the
Study of IBD. STRIDE-II: An Update on the Selecting Therapeutic
Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the
International Organization for the Study of IBD (IOIBD): Determining
Therapeutic Goals for Treat-to-Target strategies in IBD.
Gastroenterology. 2021 Apr;160(5):1570-1583. doi:
10.1053/j.gastro.2020.12.031. Epub 2021 Feb 19. PMID: 33359090.
- Saydy N, Moubayed SP, Bussières M, Janjua A, Kilty S, Lavigne F,
Monteiro E, Nayan S, Piché M, Smith K, Sommer D, Sowerby L, Tewfik MA,
Witterick IJ, Wright E, Desrosiers M. What is the optimal outcome
after endoscopic sinus surgery in the treatment of chronic
rhinosinusitis? A consultation of Canadian experts. J Otolaryngol Head
Neck Surg. 2021 Jun 16;50(1):36. doi: 10.1186/s40463-021-00519-9.
PMID: 34134762; PMCID: PMC8210358.)
- Maniakas A, Asmar MH, Renteria Flores AE, Nayan S, Alromaih S, Mfuna
Endam L, Desrosiers MY. Staphylococcus aureus on Sinus Culture
Is Associated With Recurrence of Chronic Rhinosinusitis After
Endoscopic Sinus Surgery. Front Cell Infect Microbiol. 2018 May
15;8:150.
- Maniakas A, Asmar MH, Renteria AE, Nayan S, Alromaih S, Endam LM,
Sampalis JS, Desrosiers M. Azithromycin in high-risk, refractory
chronic rhinosinusitus after endoscopic sinus surgery and
corticosteroid irrigations: a double-blind, randomized,
placebo-controlled trial. Int Forum Allergy Rhinol. 2021
Apr;11(4):747-754. doi: 10.1002/alr.22691. Epub 2020 Sep 15. PMID:
32929891
- Renteria AE, Maniakas A, Pelletier A, Filali-Mouhim A, Brochiero E,
Valera CP, Adam D, Mfuna Endam L, Desrosiers M. Successful recovery
from ESS is characterised by transcriptomic changes suggesting
decreased type 1 inflammation and epithelial restoration. In press,
Otolaryngol Head Neck Surg.